GX-G3, a long-acting G-CSF, compared with pegfilgrastim in reducing duration of severe neutropenia after chemotherapy for non-Hodgkin's lymphoma.

Ertan-Ahmed, SenemKiehl, Michael G.Radinoff, AtanasGraklanov, VaskoTzvetkov, NikolayMihaescu, RodicaOzatli, DuzgunAtalay, FigenTurgut, BurhanCho, Seok-GuRekhtman, GrygoriySahin, AdemOncel, HaticeChoi, YuriYang, Sang-InChoi, Yoon-JeongHeo, MinKyuSung, Young Chul2020-11-092020-11-0920190732-183Xhttp://hdl.handle.net/11727/5016enginfo:eu-repo/semantics/closedAccessGX-G3, a long-acting G-CSF, compared with pegfilgrastim in reducing duration of severe neutropenia after chemotherapy for non-Hodgkin's lymphoma.Conference Object3715000487345802410